Development of a high-speed, multiplexed sample-delivery instrument for LC-MS/MS bioanalysis

Bioanalysis

Volumn 4, Issue 9, 2012, Pages 1039-1056

  Janiszewski, John ^a   Schneider, Richard ^a   Kapinos, Brendon ^a   West, Mike ^a   Funk, Carrie ^a   Federico, James ^a   Umland, John ^a   Piotrowski, Mary ^a   Mitchell, Walter ^a   Zhang, Hui ^a   Zelesky, Veronica ^a   Gobey, Jason ^a   Whalen, Kevin ^a   Liston, Theodore ^a   Troutman, Matthew ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ANALYTIC METHOD; APRICOT DESIGNS DUAL ARM; AUTOMATION; COMPUTER PROGRAM; DATA BASE; DATA PROCESSING; HIGH THROUGHPUT SCREENING; IC 50; IN VITRO STUDY; INFORMATION SYSTEM; INSTRUMENT; LIQUID CHROMATOGRAPHY; METABOLITE; PERFORMANCE; REVIEW; SEPARATION TECHNIQUE; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INTERACTIONS; HIGH-THROUGHPUT SCREENING ASSAYS; MASS SPECTROMETRY; PHARMACEUTICAL PREPARATIONS;

EID: 84861416622     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.87     Document Type: Review

References (32)

1. Kassel DB. High-throughput strategies for in vitro ADME assays: how fast can we go ? In: Using Mass Spectrometry for Drug Metabolism Studies. Korfmacher WA (Ed.). CRC Press, Boca Raton, FL, USA, 83-102 (2005).
2. Ackermann BL, Berna MJ, Eckstein JA, Ott LW, Chaudhary AK. Current applications of liquid chromatography/mass spectrometry in pharmaceutical discovery after a decade of innovation. Annu. Rev. Anal. Chem. 1, 357-396 (2008).
3. Bleicher KH, Boehm H-J, Mueller K, Alanine AI. A guide to drug discovery: hit and lead generation: Beyond high-throughput screening. Nat. Rev. Drug Discov. 2(5), 369-378 (2003).
4. Di L, Kerns EH, Carter GT, Drug-like property concepts in pharmaceutical design. Curr. Pharm. Des. 15(19), 2184-2194 (2009).
5. Hop, CE, Cole MJ, Davidson RE et al. High throughput ADME screening: Practical considerations, impact on the portfolio and enabler of in silico ADME models. Curr. Drug Metab. 9(9), 847-853 (2008).
6. Leeson PD, St Gallay SA. The influence of the 'organizational factor' on compound quality in drug discovery. Nat. Rev. Drug Disc. 10(10), 749-765 (2011).
7. Kassel DB. In vitro ADME profiling and pharmacokinetic screening in drug discovery. In: Electrospray and MALDI Mass Spectrometry: Fundamentals, Instrumentation, Practicalities, and Biological Applications (2nd Edition). Cole RB (Ed.). John Wiley & Sons, Inc., NJ, USA, 799-824 (2010).
8. Gobey J, Cole M, Janiszewski J et al. Characterization and performance of MALDI on a triple quadrupole mass spectrometer for analysis and quantification of small molecules. Anal. Chem. 77(17), 5643-5654 (2005).
9. Gobey JS, Janiszewski J, Cole MJ. Desorption ionization techniques for quantitative analysis of drug molecules. In: Mass Spectrom. Drug Metab. Pharmacokinet. Ramanathan R (Ed.). John Wiley & Sons, Inc., NJ, USA, 341-358 (2009).
10. Deng Y, Wu J-T, Lloyd TL et al. High-speed gradient parallel liquid chromatography- tandem mass spectrometry with fully automated sample preparation for bioanalysis: 30 seconds per sample from plasma. Rapid Commun. Mass Spectrom. 16(11), 1116-1123 (2002).
11. Gibson D, Saunders K. Ultra-high throughput quantitative analysis using medusa parallel sprayer. Presented at: The 52nd American Society of Mass Spectrometry Conference. Nashville, TN, USA, 23-27 May 2004.
12. Halladay JS, Delarosa EM, Tran D, Wang L, Wong S, Khojasteh SC. High-throughput , 384-well, LC-MS/MS CYP inhibition assay using automation , cassette-analysis technique and streamlined data analysis. Drug Metab. Lett. 5(3), 220-230 (2011).
13. Xu R, Manuel, M, Cramlett J, Kassel DB. A high throughput metabolic stability screening workflow with automated assessment of data quality in pharmaceutical industry. J. Chromatogr. A 1217(10), 1616-1625 (2010).
14. Zhang H, Zelesky V, Schneider R et al. Improving the throughput of in vitro ADME screens using cassette analysis and polarity switching. Presented at: The 58th American Society of Mass Spectrometry Conference. Salt Lake City, UT, USA, 23-27 May 2010.
15. Zhang J, Shou WZ, Vath M, Kieltyka, K et al. An integrated bioanalytical platform for supporting high-throughput serum protein binding screening. Rapid Commun. Mass Spectrom. 24(24), 3593-3601 (2010).
16. Janiszewski JS, Liston TE, Cole M J. Perspectives on bioanalytical mass spectrometry and automation in drug discovery. Curr. Drug Metab. 9(9), 986-994 (2008).
17. Luippold AH, Arnhold T, Joerg W, Suessmuth RD. An integrated platform for fully automated high-throughput LC-MS/ MS analysis of in vitro metabolic stability assay samples. Int. J. Mass Spectrom. 296(1-3), 1-9 (2010).
18. Luippold AH, Arnhold T, Joerg W, Krueger B, Suessmuth RD. Application of a Rapid and Integrated Analysis System (RIAS) as a high-throughput processing tool for in vitro ADME samples by liquid chromatography/ tandem mass spectrometry. J. Biomol. Screen. 16(3), 370-377 (2011).
19. Jian W, Romm MV, Edom RW, Miller VP, LaMarr WA, Weng N. Evaluation of a high-throughput online solid phase extraction-tandem mass spectrometry system for in vivo bioanalytical studies. Anal. Chem. 83(21), 8259-8266 (2011).
20. Youdim KA, Saunders KC. A review of LC-MS techniques and high-throughput approaches used to investigate drug metabolism by cytochrome P450s. J. Chromatogr. B 878(17-18), 1326-1336 (2010).
21. Shou WZ, Zhang J. Recent development in high-throughput bioanalytical support for in vitro ADMET profiling. Expert Opin. Drug Metab. Tox. 6(3), 321-336 (2010).
22. Whalen K, Gobey J, Janiszewski J. A centralized approach to tandem mass spectrometry method development for high-throughput ADME screening. Rapid Commun. Mass Spectrom. 20(10), 1497-1503 (2006).
23. Gao F, Johnson DL, Ekins S et al. Optimizing higher throughput methods to assess drug-drug interactions for CYP1A2, CYP2C9, CYP2D6, rCYP2D6 and CYP3A4 in vitro using a single point IC50. J. Biomol. Screen. 7(4), 373-382 (2002).
24. Otten JN, Hingorani GP, Hartley DP, Kragerud SD, Franklin RB. An in vitro, high throughput , seven CYP cocktail inhibition assay for the evaluation of new chemical entities using LC-MS/MS. Drug Metab. Lett. 5(1), 17-24 (2011).
25. Smith D, Sadagopan N, Zientek M, Reddy A, Cohen L. Analytical approaches to determine cytochrome P450 inhibitory potential of new chemical entities in drug discovery. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 850(1-2), 455-463 (2007).
26. Zientek M, Miller H, Smith D, Dunklee MB et al. Development of an in vitro drug-drug interaction assay to simultaneously monitor five cytochrome P450 isoforms and performance assessment using drug library compounds. J. Pharmacol. Toxicol. Methods 58(3), 206-214 (2008).
27. Youdim KA, Lyons R, Payne L, Jones BC, Saunders K. An automated, high-throughput, 384 well Cytochrome P450 cocktail IC50 assay using a rapid resolution LC-MS/MS end-point. J. Pharmaceut. Biomed. Anal. 48(1), 92-99 (2008).
28. Janiszewski JS, Rogers K J, Whalen KM et al. A high-capacity LC-MS system for the bioanalysis of samples generated from plate-based metabolic screening. Anal. Chem. 73(7), 1495-1501 (2001).
29. Freiwald S, Smith D, Winters R. An LC-MS/ MS dual column method to support high throughput bioanalysis of in vitro ADME screening samples. Am. Pharm. Rev. 7(4), 16, 18-19 (2004).
30. Zhang H, Janiszewski JS, Schneider RP. Improving the success rate of 'trap and elute' chromatography for high-throughput LC- MS/MS bioanalysis. Presented at: The 57th American Society of Mass Spectrometry Conference. Philadelphia, PA, USA, 1-4 June 2009.
31. Miller E, Shirey K, Clouser-Roche A, Zelesky V, Whalen et al. Collaborative methods development in drug discovery. Presented at: The 59th American Society of Mass Spectrometry Conference. Denver, CO, USA, 5-9 June 2011.
32. Zelesky V, Schneider RP, Janiszewski JS, Zhang H. High throughput LC-MS methods development for in vitro ADME screening. Presented at: The 59th American Society of Mass Spectrometry Conference. Denver, CO, USA, 5-9 June 2011.